Staphylococcus aureus cap5O and cap5P genes functionally complement mutations affecting enterobacterial...

Area of Science:

• Microbiology
• Molecular Biology
• Bacterial Genetics

Background:

• Staphylococcus aureus produces a type 5 capsule, a key virulence factor.
• Escherichia coli mutants lacking rffE or rffD are defective in enterobacterial common antigen (ECA) expression.
• The genetic basis for capsule biosynthesis and its relationship with ECA in Gram-negative bacteria are areas of active research.

Purpose of the Study:

• To investigate the function of Staphylococcus aureus cap5P and cap5O genes in capsule biosynthesis.
• To determine if these genes can complement defects in Escherichia coli ECA synthesis.
• To elucidate the enzymatic roles of Cap5P and Cap5O in the synthesis of the capsule precursor UDP-ManNAcA.

Main Methods:

• Genetic complementation assays using Escherichia coli mutant strains.
• Analysis of enterobacterial common antigen expression.
• Biochemical characterization of Cap5P and Cap5O enzyme activities.

Main Results:

• Staphylococcus aureus cap5P and cap5O genes restored ECA expression in Escherichia coli rffE and rffD mutants, respectively.
• Cap5P and Cap5O were identified as likely UDP-GlcNAc 2-epimerase and UDP-ManNAc dehydrogenase, respectively.
• These enzymes are involved in the synthesis of UDP-ManNAcA, a precursor for the type 5 capsule.

Conclusions:

• The Staphylococcus aureus cap5P and cap5O genes play essential roles in the biosynthesis of the type 5 capsule.
• These genes encode enzymes with specific functions in synthesizing the UDP-ManNAcA precursor.
• The findings provide insights into the conservation and function of capsule biosynthesis pathways across different bacterial species.